The Ins and Outs of Running a Biopharma Startup
October 14, 2026
Dr. Kate Rochlin (Ph.D. ’14), president and chief operating officer of IN8bio, a clinical-stage cell therapy and T cell engager company, shared her journey and practical advice candidly on Sept. 8 in Uris Auditorium with an audience consisting of Accelerating BioVenture Innovation participants and faculty and students from the Tri-Institutional community.
Dr. Dan Landau Named Inaugural Chair of the Department of Systems and Computational Biomedicine at Weill Cornell Medicine
August 24, 2026
Dr. Dan Landau, an internationally recognized cancer researcher and geneticist whose pioneering advances include single-cell-profiling technology innovation and an artificial intelligence-powered liquid biopsy for detecting tumor DNA in blood, will serve as the inaugural chair of the Department of Systems and Computational Biomedicine, effective Sept. 1.Charlson Comorbidity Index Shows Promise in Population Health Management
July 27, 2026
A study by Dr. Mary Charlson and her colleagues identifies patients with comorbidity that are at highest risk for unplanned hospitalizations and suggests early interventions to reduce that risk.
BioVenture eLab Secures $1.5 million State Grant to Broaden Weill Cornell Entrepreneurial Ecosystem
July 10, 2026
Weill Cornell Medicine has received a four-year, $1.5 million grant from New York’s Empire State Development to increase resources available through BioVenture eLab, the institution’s hub for biomedical entrepreneurship.
Gene Therapy Shows Promise for Life-Threatening Inherited Heart Disease
June 17, 2026
A new gene therapy appears to be safe in patients diagnosed with Friedreich ataxia cardiomyopathy, a progressive and fatal inherited cardiac disease, according to a phase 1 clinical trial led by Weill Cornell Medicine researchers. The treatment may also reduce heart damage, although further investigation is needed.
Researchers-turned-inventors Recognized at Bearers of Innovation Celebration
June 16, 2026
On May 20, Cornell’s Center for Technology Licensing (CTL) brought together inventors from across colleges and campuses in Ithaca and at Weill Cornell Medicine in New York City for Bearers of Innovation: A One Cornell Celebration. The event recognized 82 lead inventors who submitted their first invention disclosure to CTL in fiscal year 2024 or fiscal year 2025, and 306 inventors whose technologies were licensed or optioned during that same period.
Innovators Pitch Cell Therapies and AI Tools at Biomedical Innovation Challenge
June 10, 2026
The eighth cohort of the Biomedical Innovation Challenge showcased its innovations and development plans during a lightning round of pitches and judges’ questions on June 4 in the Belfer Research Building.
A Breakthrough Single-Cell Method for Mapping DNA-Protein Interactions
June 4, 2026
A new technology allows scientists to map, in single cells, the DNA binding sites of transcription factors and other regulatory proteins that control gene activity, according to a study led by investigators at Weill Cornell Medicine and the New York Genome Center. With key advantages over methods currently in use, the technology is expected to be a powerful addition to biologists’ toolkit for studying cells in health and disease.
BioInnovate Conference Showcases Path from Innovation to Scale Through a Growing Ecosystem
May 7, 2026
Over 200 scientists, startup founders and partners in government and industry gathered at Uris Auditorium on April 23 for the 2026 BioInnovate Conference. The event, hosted by BioVenture eLab, part of Weill Cornell Medicine Enterprise Innovation, celebrates the growing ecosystem that turns scientific discovery into scalable healthcare solutions. Speakers and panelists discussed topics ranging from AI in clinical trials to reshoring domestic drug discovery and manufacturing.
